Abithas, Inc.

In the U.S., over $10 billion annually in costs are attributed to inhaler misuse, in spite of an existing $600 million inhaler accessory device market. Abithas, Inc.: • Delaware incorporated entity. • Certified under the Illinois Angel Investment Tax Credit Program. Problem: • In the U.S., over 55 million people with asthma and COPD use metered-dose inhalers ("MDIs"). • Up to 90% of MDI users fail to get the intended benefits from their medications due to inhaler misuse. • Up to 85% of healthcare providers can't properly demonstrate MDI use or omit critical steps. Solution: • The InspirEase®HFA device. A low-tech device that can improve lives and save billions of dollars • The InspirEase®HFA is designed to eliminate the misuse of common, metered-dose inhaler misuse for children and adults (and caregivers).

• Employees 1
• Founded 2015